Compare Rush Street Interactive Inc (RSI) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rush Street Interactive Inc vs BIO-TECHNE Corp — how do they compare? Rush Street Interactive Inc trades at $25.14 (market cap $2.88B), while BIO-TECHNE Corp trades at $72.13 (market cap $11.24B). The key difference: BIO-TECHNE Corp is far larger — about 3.9× Rush Street Interactive Inc's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while Rush Street Interactive Inc pays none. Which is the better fit depends on your goals.
| RSI | TECH | |
|---|---|---|
Market Cap | $2.88B | $11.24B |
Sector | Technology | Health |
52-Week High | $34.52 | $72.29 |
52-Week Low | $15.89 | $43.31 |
Enterprise Value | $2.54B | $11.32B |
Dividend Yield | — | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Rush Street Interactive (RSI) trades at $24.88, down 0.8% with strong technical momentum indicators showing oversold conditions (RSI at 16-17). The company reported record Q2 2026 revenue of $393.8 million, up 46% year-over-year, and raised full-year guidance. Analyst consensus remains strongly bullish with 10 buy ratings and a $34.75 price target representing 40% upside potential.
RSI demonstrates robust revenue growth and expanding market presence but faces valuation concerns with a high P/E of 80.26. Key risks include competitive pressures in online gambling and regulatory uncertainties. The combination of strong fundamentals, positive analyst sentiment, and oversold technical conditions suggests potential for near-term recovery.
Bio-Techne (TECH) trades at $72.29, up 0.54% today, with a bullish technical signal from moving averages and a consensus analyst price target of $71.67. Recent earnings showed mixed results, with a Q4 2025 beat but a Q1 2026 miss. The company maintains strong gross margins at 64.96% but faces declining net income margins, down to 6.01% in 2025. Positive cash flow trends and a pending acquisition by Merck highlight ongoing corporate developments.
Outlook is balanced with growth potential from product innovation and acquisition synergies, but risks include earnings volatility, high valuation multiples, and shareholder litigation over the merger terms. Institutional sentiment is split evenly between buy and hold ratings, reflecting cautious optimism amid execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Rush Street Interactive Inc
Rush Street Interactive, Inc. is a digital gaming and sports betting company operating in the regulated U.S. and international markets. The company owns and operates online casino (iGaming) and sports wagering platforms, including BetRivers and PlaySugarHouse brands. RSI focuses on providing a secure and high-quality online gaming experience, leveraging its proprietary technology platform and commitment to responsible gaming.
Read more on RSI →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
